OUTCOME OF SULFONYLUREA AND INSULIN VERSUS INCRETIN-BASED TREATMENT IN TYPE 2 DIABETES PATIENTS UNCONTROLLED ON PRIOR METFORMIN MONO THERAPY: RESULTS OF DIAREGIS

Metformin is the first line drug for patients with type-2 diabetes. The impact of different treatment escalation strategies after metformin failure on glucose control and morbidity has however not been investigated in real life. DiaRegis is a multicenter registry in 3,810 patients with type-2